Colorectal Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colorectal Cancer, including details on symptoms, genetics, screening, treatment, information.

Volume 4 (2007), Issue 7 (July)

1. Plasma lysophosphatidylcholine levels: potential biomarkers for colorectal cancer.
   J Clin Oncol, 25(19): 2696-701. [Abstract] [Full-text]
2. Gynecologic cancer prevention in Lynch syndrome/hereditary nonpolyposis colorectal cancer families.
   Obstet Gynecol, 110(1): 18-25. [Abstract] [Full-text]
3. The role of trophinin, an adhesion molecule unique to human trophoblasts, in progression of colorectal cancer.
   Int J Cancer, 121(5): 1072-8. [Abstract] [Full-text]
4. Serum matrix metalloproteinase 7 levels identifies poor prognosis advanced colorectal cancer patients.
   Int J Cancer, 121(5): 1066-71. [Abstract] [Full-text]
5. No excess risk for colorectal cancer among subjects seropositive for the JC polyomavirus.
   Int J Cancer, 121(5): 1098-102. [Abstract] [Full-text]
6. Patterns of PIK3CA alterations in familial colorectal and endometrial carcinoma.
   Int J Cancer, 121(4): 915-20. [Abstract] [Full-text]
7. Prognostic significance of matrix metalloproteinases-1, -2, -7 and -13 and tissue inhibitors of metalloproteinases-1, -2, -3 and -4 in colorectal cancer.
   Int J Cancer, 121(4): 714-23. [Abstract] [Full-text]
8. Colorectal cancer survival in the Nordic countries and the United Kingdom: excess mortality risk analysis of 5 year relative period survival in the period 1999 to 2000.
   Int J Cancer, 121(5): 1115-22. [Abstract] [Full-text]
9. Synergistic antitumor effects of celecoxib with 5-fluorouracil depend on IFN-gamma.
   Int J Cancer, 121(4): 878-83. [Abstract] [Full-text]
10. Prostaglandin F(2alpha) stimulates motility and invasion in colorectal tumor cells.
    Int J Cancer, 121(4): 734-40. [Abstract] [Full-text]
11. Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials.
    J Natl Cancer Inst, 99(13): 998-1003. [Abstract] [Full-text]
12. NAT2 fast acetylator genotype is associated with an increased risk of colorectal cancer in Taiwan.
    Dis Colon Rectum, 50(7): 981-9. [Abstract] [Full-text]
13. A diverting stoma is not necessary when performing a handsewn coloanal anastomosis for lower rectal cancer.
    Dis Colon Rectum, 50(7): 1040-6. [Abstract] [Full-text]
14. Colorectal carcinoma: a retrospective, descriptive study of age, gender, subsite, stage, and differentiation in Iran from 1995 to 2001 as observed in Tehran University.
    Dis Colon Rectum, 50(7): 990-5. [Abstract] [Full-text]
15. Melanoma of the anal canal: a case series.
    Dis Colon Rectum, 50(7): 1004-10. [Abstract] [Full-text]
16. Combining radioisotopic and blue-dye technique does not improve the false-negative rate in sentinel lymph node mapping for colorectal cancer.
    Dis Colon Rectum, 50(7): 962-70. [Abstract] [Full-text]
17. Detection of metachronous neoplasms in colorectal cancer patients: identification of risk factors.
    Dis Colon Rectum, 50(7): 971-80. [Abstract] [Full-text]
18. The impact of technical factors on outcome of restorative proctocolectomy for familial adenomatous polyposis.
    Dis Colon Rectum, 50(7): 952-61. [Abstract] [Full-text]
19. Apoptosis and chemo-resistance in colorectal cancer.
    J Surg Oncol, 96(1): 77-88. [Abstract] [Full-text]
20. Endobronchial metastases from colon cancer without liver metastases: report of eight cases.
    Dis Colon Rectum, 50(7): 1087-9. [Abstract] [Full-text]
21. NSAIDs and colorectal cancer risk: do administrative data support a chemopreventive effect?
    J Gen Intern Med, 22(8): 1166-71. [Abstract] [Full-text]
22. Improving colorectal cancer screening in primary care practice: innovative strategies and future directions.
    J Gen Intern Med, 22(8): 1195-205. [Abstract] [Full-text]
23. Magnetic resonance colonography without bowel cleansing: a prospective cross sectional study in a screening population.
    Gut, 56(8): 1079-85. [Abstract] [Full-text]
24. CDX2 promotes anchorage-independent growth by transcriptional repression of IGFBP-3.
    Oncogene, 26(32): 4725-9. [Abstract] [Full-text]
25. Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes.
    Oncogene, 26(32): 4679-88. [Abstract] [Full-text]
26. Essential roles of high-mobility group box 1 in the development of murine colitis and colitis-associated cancer.
    Biochem Biophys Res Commun, 360(2): 394-400. [Abstract] [Full-text]
27. Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial.
    Lancet, 370(9582): 143-52. [Abstract] [Full-text]
28. Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial.
    Lancet, 370(9582): 135-42. [Abstract] [Full-text]
29. Yttrium 90 microsphere selective internal radiation treatment of hepatic colorectal metastases.
    Arch Surg, 142(7): 675-82. [Abstract] [Full-text]
30. The significance of inadvertent splenectomy during colorectal cancer resection.
    Arch Surg, 142(7): 668-74. [Abstract] [Full-text]
31. Randomized, multicenter trial of antibiotic prophylaxis in elective colorectal surgery: single dose vs 3 doses of a second-generation cephalosporin without metronidazole and oral antibiotics.
    Arch Surg, 142(7): 657-61. [Abstract] [Full-text]
32. Oncological outcome of local vs radical resection of low-risk pT1 rectal cancer.
    Arch Surg, 142(7): 649-55; discussion 656. [Abstract] [Full-text]
33. Stents for palliation of obstructive metastatic colon cancer: impact on management and chemotherapy administration.
    Arch Surg, 142(7): 619-23; discussion 623. [Abstract] [Full-text]
34. Cyclin D1 gene G870A polymorphism predicts response to neoadjuvant radiotherapy and prognosis in rectal cancer.
    Int J Radiat Oncol Biol Phys, 68(4): 1094-101. [Abstract] [Full-text]
35. Tamoxifen forms DNA adducts in human colon after administration of a single [14C]-labeled therapeutic dose.
    Cancer Res, 67(14): 6995-7002. [Abstract] [Full-text]
36. Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer.
    Cancer Res, 67(14): 6844-53. [Abstract] [Full-text]
37. Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group.
    J Clin Oncol, 25(21): 3061-8. [Abstract] [Full-text]
38. A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer.
    J Natl Cancer Inst, 99(14): 1120-9. [Abstract] [Full-text]
39. Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon.
    Oncogene, 26(33): 4833-41. [Abstract] [Full-text]
40. Human scribble accumulates in colorectal neoplasia in association with an altered distribution of beta-catenin.
    Hum Pathol, 38(8): 1273-81. [Abstract] [Full-text]
41. Screening CT colonography: how I do it.
    AJR Am J Roentgenol, 189(2): 290-8. [Abstract] [Full-text]
42. CT colonography for follow-up after surgery for colorectal cancer.
    AJR Am J Roentgenol, 189(2): 283-9. [Abstract] [Full-text]
43. Cellular mechanisms involved in the melatonin inhibition of HT-29 human colon cancer cell proliferation in culture.
    J Pineal Res, 43(2): 195-205. [Abstract] [Full-text]
44. Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer.
    N Engl J Med, 357(4): 360-9. [Abstract] [Full-text]
45. Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells.
    Mol Pharmacol, 72(2): 395-406. [Abstract] [Full-text]
46. Dietary fat and risk of colon and rectal cancer with aberrant MLH1 expression, APC or KRAS genes.
    Cancer Causes Control, 18(8): 865-79. [Abstract] [Full-text]
47. Lack of evidence for effect modification by estrogen of association between body mass index and colorectal cancer risk among postmenopausal women.
    Cancer Causes Control, 18(8): 793-9. [Abstract] [Full-text]
48. Dietary carbohydrate, glycemic index, and glycemic load and the risk of colorectal cancer in the BCDDP cohort.
    Cancer Causes Control, 18(8): 853-63. [Abstract] [Full-text]
49. Epigenetic inactivation of the metastasis suppressor RECK enhances invasion of human colon cancer cells.
    J Cell Physiol, 213(1): 65-9. [Abstract] [Full-text]
50. Determining the treatment strategy for colorectal neoplastic lesions: endoscopic assessment or the non-lifting sign for diagnosing invasion depth?
    Endoscopy, 39(8): 701-5. [Abstract] [Full-text]
51. Overexpression of the obesity hormone leptin in human colorectal cancer.
    J Clin Pathol, 60(8): 902-6. [Abstract] [Full-text]
52. The total mesorectal excision specimen for rectal cancer: a review of its pathological assessment.
    J Clin Pathol, 60(8): 849-55. [Abstract] [Full-text]
53. Histopathological risk factors for lymph node metastasis in submucosal invasive colorectal carcinoma of pedunculated or semipedunculated type.
    J Clin Pathol, 60(8): 912-5. [Abstract] [Full-text]
54. Eradication of hepatoma and colon cancer in mice with Flt3L gene therapy in combination with 5-FU.
    Cancer Immunol Immunother, 56(10): 1605-13. [Abstract] [Full-text]
55. Lymphangiogenesis in colorectal cancer--prognostic and therapeutic aspects.
    Int J Cancer, 121(7): 1401-9. [Abstract] [Full-text]
56. Abnormal expression of M1/MUC5AC mucin in distal colon of patients with diverticulitis, ulcerative colitis and cancer.
    Int J Cancer, 121(7): 1543-9. [Abstract] [Full-text]
57. Mutations of the PIK3CA gene in hereditary colorectal cancers.
    Int J Cancer, 121(7): 1627-30. [Abstract] [Full-text]

© 2004-2008 Colorectal Cancer Research Today. All Rights Reserved.